Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Accounts Payables: 2016-2021

Historic Accounts Payables for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $1.4 million.

  • ENDRA Life Sciences' Accounts Payables rose 9.37% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year increase of 9.37%. This contributed to the annual value of $910,183 for FY2020, which is 46.73% down from last year.
  • According to the latest figures from Q3 2021, ENDRA Life Sciences' Accounts Payables is $1.4 million, which was down 4.34% from $1.5 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Accounts Payables ranged from a high of $1.7 million in Q4 2019 and a low of $162,302 during Q2 2017.
  • Its 3-year average for Accounts Payables is $1.2 million, with a median of $1.3 million in 2020.
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 362.95% in 2018, then tumbled by 52.45% in 2021.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Accounts Payables stood at $848,214 in 2017, then grew by 14.90% to $974,583 in 2018, then surged by 75.31% to $1.7 million in 2019, then tumbled by 46.73% to $910,183 in 2020, then grew by 9.37% to $1.4 million in 2021.
  • Its Accounts Payables was $1.4 million in Q3 2021, compared to $1.5 million in Q2 2021 and $686,650 in Q1 2021.